Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Hansen, Christopher B
NCT05996835: Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (SA-AKI)	Recruiting	2	320	Europe, Canada, Japan, US, RoW	TIN816 70 mg lyophilisate powder, Placebo	Novartis Pharmaceuticals	Acute Kidney Injury Due to Sepsis	12/25	02/26
NCT04922736: Patient Reported Outcomes with UVA-1 Therapy for Treatment of Sclerosing Skin Diseases	Enrolling by invitation	N/A	30	US	UVA-1 Phototherapy	University of Utah	Scleroderma, Systemic, Morphea, Graft Vs Host Disease	12/25	12/25